Clinical trial
Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)
NCT02433613 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- May 31, 2019
- Enrollment
- 1,071 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.